Cargando…
Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production
An immunodominant epitope of myelin basic protein (MBP), VHFFKNIVTPRTP (p87-99), is a major target of T cells in lesions of multiple sclerosis (MS) and in experimental allergic encephalomyelitis (EAE). T cells found in EAE lesions bear the same amino acids in the third complementary determining regi...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191798/ https://www.ncbi.nlm.nih.gov/pubmed/7525850 |
Ejemplares similares
-
Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis
por: Wang, Xiaohua, et al.
Publicado: (2016) -
Tolerance Induction and Autoimmune Encephalomyelitis Amelioration After Administration of Myelin Basic Protein–derived Peptide
por: Marusic, Suzana, et al.
Publicado: (1997) -
Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Arellano, Gabriel, et al.
Publicado: (2015) -
Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
por: Tichauer, Juan E., et al.
Publicado: (2023) -
A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis
Publicado: (1992)